{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T15:37:34Z","timestamp":1765294654286,"version":"3.37.3"},"reference-count":37,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":469,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100004622","name":"Dutch Cancer Society","doi-asserted-by":"crossref","award":["NKI1998-1854 and NK12004-3088 and NKI2007-3756"],"award-info":[{"award-number":["NKI1998-1854 and NK12004-3088 and NKI2007-3756"]}],"id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Netherlands Organization of Scientific Research","award":["NWO 91109024"],"award-info":[{"award-number":["NWO 91109024"]}]},{"name":"Pink Ribbon","award":["110005"],"award-info":[{"award-number":["110005"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Cancer"],"published-print":{"date-parts":[[2014,12,15]]},"DOI":"10.1002\/ijc.28941","type":"journal-article","created":{"date-parts":[[2014,5,2]],"date-time":"2014-05-02T08:30:58Z","timestamp":1399019458000},"page":"2940-2949","source":"Crossref","is-referenced-by-count":13,"title":["Relevance and efficacy of breast cancer screening in<i>BRCA1<\/i>and<i>BRCA2<\/i>mutation carriers above 60 years: A national cohort study"],"prefix":"10.1002","volume":"135","author":[{"given":"Sepideh","family":"Saadatmand","sequence":"first","affiliation":[{"name":"Department of Surgery; Erasmus University Medical Centre; Rotterdam The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet R.","family":"Vos","sequence":"additional","affiliation":[{"name":"Department of Epidemiology; University Medical Centre Groningen; The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maartje J.","family":"Hooning","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology; Erasmus University Medical Centre-Cancer Institute; Rotterdam The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan C.","family":"Oosterwijk","sequence":"additional","affiliation":[{"name":"Department of Genetics; University Medical Centre Groningen; The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linetta B.","family":"Koppert","sequence":"additional","affiliation":[{"name":"Department of Surgery; Erasmus University Medical Centre; Rotterdam The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geertruida H.","family":"de Bock","sequence":"additional","affiliation":[{"name":"Department of Epidemiology; University Medical Centre Groningen; The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margreet G.","family":"Ausems","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics; University Medical Centre Utrecht; The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christi J.","family":"van Asperen","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics; Leiden University Medical Centre; The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cora M.","family":"Aalfs","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics; Academic Medical Centre; Amsterdam The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Encarna B.","family":"G\u00f3mez Garcia","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics; Maastricht University Medical Centre; The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanne","family":"Meijers-Heijboer","sequence":"additional","affiliation":[{"name":"Department of Clinical Genetics; VU University Medical Centre; Amsterdam The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicoline","family":"Hoogerbrugge","sequence":"additional","affiliation":[{"name":"Department of Human Genetics; Radboud University Medical Centre; Nijmegen The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne","family":"Piek","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology; The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam; The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Seynaeve","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology; Erasmus University Medical Centre-Cancer Institute; Rotterdam The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelis","family":"Verhoef","sequence":"additional","affiliation":[{"name":"Department of Surgery; Erasmus University Medical Centre; Rotterdam The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matti","family":"Rookus","sequence":"additional","affiliation":[{"name":"Department of Epidemiology; The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital; Amsterdam The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madeleine M.","family":"Tilanus-Linthorst","sequence":"additional","affiliation":[{"name":"Department of Surgery; Erasmus University Medical Centre; Rotterdam The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON)","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,5,20]]},"reference":[{"key":"10.1002\/ijc.28941-BIB0001|ijc28941-cit-0001","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.7545954","article-title":"A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1","volume":"266","author":"Miki","year":"1994","journal-title":"Science"},{"key":"10.1002\/ijc.28941-BIB0002|ijc28941-cit-0002","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1126\/science.8091231","article-title":"Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13","volume":"265","author":"Wooster","year":"1994","journal-title":"Science"},{"key":"10.1002\/ijc.28941-BIB0003|ijc28941-cit-0003","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1093\/jnci\/djt095","article-title":"Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE","volume":"105","author":"Mavaddat","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"10.1002\/ijc.28941-BIB0004|ijc28941-cit-0004","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","article-title":"Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies","volume":"72","author":"Antoniou","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1002\/ijc.28941-BIB0005|ijc28941-cit-0005","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s10549-010-0805-3","article-title":"Penetrance of breast cancer, ovarian cancer and contralateral breast cancer in BRCA1 and BRCA2 families: high cancer incidence at older age","volume":"124","author":"Kolk","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1002\/ijc.28941-BIB0006|ijc28941-cit-0006","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1200\/JCO.2009.22.7991","article-title":"Survival analysis of cancer risk reduction strategies for BRCA1\/2 mutation carriers","volume":"28","author":"Kurian","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1002\/ijc.28941-BIB0007|ijc28941-cit-0007","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3322\/canjclin.57.2.75","article-title":"American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography","volume":"57","author":"Saslow","year":"2007","journal-title":"CA Cancer J Clin"},{"issue":"Suppl 6","key":"10.1002\/ijc.28941-BIB0008|ijc28941-cit-0008","doi-asserted-by":"crossref","first-page":"vi31","DOI":"10.1093\/annonc\/mdr373","article-title":"BRCA in breast cancer: ESMO clinical practice guidelines","volume":"22","author":"Balmana","year":"2011","journal-title":"Ann Oncol"},{"key":"10.1002\/ijc.28941-BIB0009|ijc28941-cit-0009","unstructured":"National Comprehensive Cancer Network (NCCN) NCCN clinical practice guidelines in oncology (NCCN guidelines): genetic\/familial high-risk assessment: breast and ovarian 2012 http:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/genetics_screening.pdf"},{"key":"10.1002\/ijc.28941-BIB0010|ijc28941-cit-0010","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1158\/1055-9965.1989.13.12","article-title":"Utilization of screening and preventive surgery among unaffected carriers of a BRCA1 or BRCA2 gene mutation","volume":"13","author":"Wainberg","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1002\/ijc.28941-BIB0011|ijc28941-cit-0011","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1002\/ijc.23340","article-title":"International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers","volume":"122","author":"Metcalfe","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1002\/ijc.28941-BIB0012|ijc28941-cit-0012","unstructured":"National Institute for Health and Clinical Excellence guidelines (NICE) NICE clinical guideline 164. Familial breast cancer: classification and care of people at risk of familial breast cancer and management of breast cancer and related risks in people with a family history of breast cancer 2013 http:\/\/www.nice.org.uk\/nicemedia\/live\/14188\/64202\/64202.pdf"},{"key":"10.1002\/ijc.28941-BIB0013|ijc28941-cit-0013","unstructured":"Nationaal Borstkanker Overleg Nederland (NABON) Richtlijn mammacarcinoom (breast cancer national guideline) 2012 http:\/\/oncoline.nl\/richtlijn\/doc\/index.php?type=pda&richtlijn_id=828"},{"key":"10.1002\/ijc.28941-BIB0014|ijc28941-cit-0014","unstructured":"http:\/\/www.vkgn.org\/images\/Vakinformatie\/Richtlijnen_en_protocollen\/StOET_VKGN_richtlijn_erfelijke_tumoren.pdf"},{"key":"10.1002\/ijc.28941-BIB0015|ijc28941-cit-0015","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1200\/JCO.2006.09.1066","article-title":"Meta-analysis of BRCA1 and BRCA2 penetrance","volume":"25","author":"Chen","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1002\/ijc.28941-BIB0016|ijc28941-cit-0016","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/ijc.22789","article-title":"Surveillance for familial breast cancer: differences in outcome according to BRCA mutation status","volume":"121","author":"Moller","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1002\/ijc.28941-BIB0017|ijc28941-cit-0017","doi-asserted-by":"crossref","first-page":"5265","DOI":"10.1200\/JCO.2009.27.2294","article-title":"BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study","volume":"28","author":"Rijnsburger","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1002\/ijc.28941-BIB0018|ijc28941-cit-0018","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1016\/S0140-6736(05)66481-1","article-title":"Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS)","volume":"365","author":"Leach","year":"2005","journal-title":"Lancet"},{"key":"10.1002\/ijc.28941-BIB0019|ijc28941-cit-0019","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jama.292.11.1317","article-title":"Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination","volume":"292","author":"Warner","year":"2004","journal-title":"JAMA"},{"key":"10.1002\/ijc.28941-BIB0020|ijc28941-cit-0020","doi-asserted-by":"crossref","first-page":"7357","DOI":"10.1158\/1078-0432.CCR-07-0689","article-title":"BRCA1 mutation and young age predict fast breast cancer growth in the Dutch, United Kingdom, and Canadian magnetic resonance imaging screening trials","volume":"13","author":"Tilanus-Linthorst","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1002\/ijc.28941-BIB0021|ijc28941-cit-0021","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s10549-009-0476-0","article-title":"Physical activity and the risk of breast cancer in BRCA1\/2 mutation carriers","volume":"120","author":"Pijpe","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1002\/ijc.28941-BIB0022|ijc28941-cit-0022","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1093\/annonc\/mdt134","article-title":"Substantial breast cancer risk reduction and potential survival benefit after bilateral mastectomy when compared with surveillance in healthy BRCA1 and BRCA2 mutation carriers: a prospective analysis","volume":"24","author":"Heemskerk-Gerritsen","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1002\/ijc.28941-BIB0023|ijc28941-cit-0023","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10549-009-0685-6","article-title":"Is the breast-conserving treatment with radiotherapy appropriate in BRCA1\/2 mutation carriers? Long-term results and review of the literature","volume":"120","author":"Kirova","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1002\/ijc.28941-BIB0024|ijc28941-cit-0024","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10549-010-0894-z","article-title":"Local therapy in BRCA1 and BRCA2 mutation carriers with operable breast cancer: comparison of breast conservation and mastectomy","volume":"121","author":"Pierce","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1002\/ijc.28941-BIB0025|ijc28941-cit-0025","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/ijc.28014","article-title":"Optimal age to start preventive measures in women with BRCA1\/2 mutations or high familial breast cancer risk","volume":"133","author":"Tilanus-Linthorst","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1002\/ijc.28941-BIB0026|ijc28941-cit-0026","doi-asserted-by":"crossref","first-page":"5887","DOI":"10.1200\/JCO.2008.19.9430","article-title":"Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers","volume":"27","author":"Graeser","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1002\/ijc.28941-BIB0027|ijc28941-cit-0027","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.ejca.2006.12.009","article-title":"Tumour characteristics, survival and prognostic factors of hereditary breast cancer from BRCA2-, BRCA1- and non-BRCA1\/2 families as compared to sporadic breast cancer cases","volume":"43","author":"Brekelmans","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1002\/ijc.28941-BIB0028|ijc28941-cit-0028","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1056\/NEJMoa050518","article-title":"Surveillance Modeling Network C. Effect of screening and adjuvant therapy on mortality from breast cancer","volume":"353","author":"Berry","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1002\/ijc.28941-BIB0029|ijc28941-cit-0029","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/S0140-6736(12)61611-0","article-title":"The benefits and harms of breast cancer screening: an independent review","volume":"380","author":"Independent UKPoBCS","year":"2012","journal-title":"Lancet"},{"key":"10.1002\/ijc.28941-BIB0030|ijc28941-cit-0030","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1158\/1055-9965.EPI-11-1196","article-title":"Differences in natural history between breast cancers in BRCA1 and BRCA2 mutation carriers and effects of MRI screening-MRISC, MARIBS, and Canadian studies combined","volume":"21","author":"Heijnsdijk","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1002\/ijc.28941-BIB0031|ijc28941-cit-0031","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/jnci\/90.15.1138","article-title":"Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations","volume":"90","author":"Lakhani","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1002\/ijc.28941-BIB0032|ijc28941-cit-0032","unstructured":"National Evaluation Team for Breast Cancer in the Netherlands (NETB) NETB report 2012: main results 2010 breast cancer screening programme in the Netherlands 2012 http:\/\/www.erasmusmc.nl\/mgz\/publicationsx\/reports\/evaluatie-borstkanker\/"},{"key":"10.1002\/ijc.28941-BIB0033|ijc28941-cit-0033","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/ijc.11226","article-title":"Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe","volume":"106","author":"Sant","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1002\/ijc.28941-BIB0034|ijc28941-cit-0034","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s10549-014-2888-8","article-title":"Should we screen BRCA1 mutation carriers only with MRI? A multicenter study","volume":"144","author":"Obdeijn","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"10.1002\/ijc.28941-BIB0035|ijc28941-cit-0035","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/sj.bjc.6603356","article-title":"Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer","volume":"95","author":"Griebsch","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1002\/ijc.28941-BIB0036|ijc28941-cit-0036","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s10549-010-0749-7","article-title":"Mammographic density does not differ between unaffected BRCA1\/2 mutation carriers and women at low-to-average risk of breast cancer","volume":"123","author":"Gierach","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"10.1002\/ijc.28941-BIB0037|ijc28941-cit-0037","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/jamainternmed.2013.307","article-title":"Breast Cancer Surveillance C. Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy","volume":"173","author":"Kerlikowske","year":"2013","journal-title":"JAMA Int Med"}],"container-title":["International Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fijc.28941","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T16:02:18Z","timestamp":1689177738000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ijc.28941"}},"subtitle":["Breast cancer screening in BRCA1\/2 carriers &gt;60 years"],"short-title":[],"issued":{"date-parts":[[2014,5,20]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12,15]]}},"URL":"https:\/\/doi.org\/10.1002\/ijc.28941","relation":{},"ISSN":["0020-7136"],"issn-type":[{"type":"print","value":"0020-7136"}],"subject":[],"published":{"date-parts":[[2014,5,20]]}}}